Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop

Last week, we learned that Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was subsidized by the American government. The situation spotlights two sets of facts that have gone largely unmentioned in the legislative debate over whether to let Medicare negotiate for lower drug prices. Fact one: Americans are facing not merely expensive drugs but prices that are examples of outright profiteering.

Read the source article at News Break
2021-10-14 19:31:00